The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...
IDIBAPS launched the first call of DYNAMIS (Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions). This IDIBAPS sche...
An international controlled clinical study published in The New England Journal of Medicine demonstrates that liquid biopsy can help identify which...
Two studies led by the IDIBAPS Liver Vascular Biology group, located at Esther Koplowitz Centre, headed by Jordi Gracia-Sancho, reveal the key role...
A team from Hospital Clínic-IDIBAPS has identified changes in brain connectivity in women who have recently experienced sexual assault and develope...
A team from the Clínic-IDIBAPS has led a study of the international consortium of neuroimage ENIGMA that has allowed us a better understanding of w...
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and cont...
The Ministry of Science, Innovation and Universities announced this Friday the winners of the 2025 National Research Awards, one of the most presti...
An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy to combat it.
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research gr...
